From Matthew Buchanan's blog, "Promote the Progress," a cogent update on Cipla of Bombay's decision to produce a generic version of Tamiflu, apparently ignoring Roche's patent.

He says,

"Indian drug companies have been making knock-off versions of patented medicines for decades. So why is this story such a big deal?

Timing. It’s everything.

The current flu scare comes just 10 months after the effective date for changes made to Indian patent law to allow patents to cover pharmaceutical compositions. The Indian system changed dramatically on January 1, 2005, and many industrial sectors were not pleased with the changes — especially the generic drug manufacturing sector of the pharmaceutical industry..."

to read on, follow the link...

posted by Solveig Singleton @ 8:27 AM | International, Patents, Pharma

Link to this Entry | Printer-Friendly | Email a Comment | Post a Comment(0)